Hyperventilation-induced reduction in cerebral blood flow: Assessment by positron emission tomography

E. M. Bednarczyk, W. F. Rutherford, G. P. Leisure, M. A. Munger, Edward A Panacek, F. D. Miraldi, J. A. Green

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The use of positron emission tomography (PET) has been well documented as a relatively noninvasive method of measuring cerebral blood flow (CBF), both globally and regionally. The utility of readily detecting alterations in CBF is apparent, particularly when applied to the evaluation of therapeutic interventions thought to influence CBF. We report the effects of hypocapnia, an experimental condition of known cerebral vasoconstriction, in ten normal volunteers. Subjects had brain blood flow evaluated utilizing H2 15O as the positron emitter before and after approximately five minutes of hyperventilation. Baseline CBF was measured as a mean ± SD of 61.2 ± 16.3 mL/min/100 g of tissue. Mean baseline arterial blood gas values were PaO2 107.4 ± 14 mm Hg, PaCO2 37.7 ± 0.89 mm Hg, and pH 7.39 (calculated from mean [H+]). Post hyperventilation, global CBF was measured as 31.1 ± 10.8 mL/min/100 g. Mean arterial blood gas values were PaO2 141.7 ± 21 mm Hg, PaCO2 19.7 ± 5 mm Hg, and pH 7.63 (calculated from mean [H+]). CBF decreased by a mean of 49.5 ± 11 percent. Data analysis using the Student's t-test showed a significant change over baseline in PaCO2 (p < 0.001) and CBF (p < 0.001), in the hyperventilated state. Correlations were noted between the decrease in CBF and change in PaCO2 (r = 0.81) as well as between hyperventilation PaCO2 and the change in CBF (r = 0.97). We conclude that, as measured by PET, CBF decreases significantly during a state of artificial hyperventilation to a degree consistent with results seen using other methods. PET appears to be a valuable tool in the assessment of interventions that could influence CBF.

Original languageEnglish (US)
Pages (from-to)456-460
Number of pages5
JournalDICP, Annals of Pharmacotherapy
Volume24
Issue number5
StatePublished - 1990
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Hyperventilation
Positron-Emission Tomography
Gases
Hypocapnia
Vasoconstriction

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bednarczyk, E. M., Rutherford, W. F., Leisure, G. P., Munger, M. A., Panacek, E. A., Miraldi, F. D., & Green, J. A. (1990). Hyperventilation-induced reduction in cerebral blood flow: Assessment by positron emission tomography. DICP, Annals of Pharmacotherapy, 24(5), 456-460.

Hyperventilation-induced reduction in cerebral blood flow : Assessment by positron emission tomography. / Bednarczyk, E. M.; Rutherford, W. F.; Leisure, G. P.; Munger, M. A.; Panacek, Edward A; Miraldi, F. D.; Green, J. A.

In: DICP, Annals of Pharmacotherapy, Vol. 24, No. 5, 1990, p. 456-460.

Research output: Contribution to journalArticle

Bednarczyk, EM, Rutherford, WF, Leisure, GP, Munger, MA, Panacek, EA, Miraldi, FD & Green, JA 1990, 'Hyperventilation-induced reduction in cerebral blood flow: Assessment by positron emission tomography', DICP, Annals of Pharmacotherapy, vol. 24, no. 5, pp. 456-460.
Bednarczyk, E. M. ; Rutherford, W. F. ; Leisure, G. P. ; Munger, M. A. ; Panacek, Edward A ; Miraldi, F. D. ; Green, J. A. / Hyperventilation-induced reduction in cerebral blood flow : Assessment by positron emission tomography. In: DICP, Annals of Pharmacotherapy. 1990 ; Vol. 24, No. 5. pp. 456-460.
@article{0fc3525997734dd39b23bd5297f61f57,
title = "Hyperventilation-induced reduction in cerebral blood flow: Assessment by positron emission tomography",
abstract = "The use of positron emission tomography (PET) has been well documented as a relatively noninvasive method of measuring cerebral blood flow (CBF), both globally and regionally. The utility of readily detecting alterations in CBF is apparent, particularly when applied to the evaluation of therapeutic interventions thought to influence CBF. We report the effects of hypocapnia, an experimental condition of known cerebral vasoconstriction, in ten normal volunteers. Subjects had brain blood flow evaluated utilizing H2 15O as the positron emitter before and after approximately five minutes of hyperventilation. Baseline CBF was measured as a mean ± SD of 61.2 ± 16.3 mL/min/100 g of tissue. Mean baseline arterial blood gas values were PaO2 107.4 ± 14 mm Hg, PaCO2 37.7 ± 0.89 mm Hg, and pH 7.39 (calculated from mean [H+]). Post hyperventilation, global CBF was measured as 31.1 ± 10.8 mL/min/100 g. Mean arterial blood gas values were PaO2 141.7 ± 21 mm Hg, PaCO2 19.7 ± 5 mm Hg, and pH 7.63 (calculated from mean [H+]). CBF decreased by a mean of 49.5 ± 11 percent. Data analysis using the Student's t-test showed a significant change over baseline in PaCO2 (p < 0.001) and CBF (p < 0.001), in the hyperventilated state. Correlations were noted between the decrease in CBF and change in PaCO2 (r = 0.81) as well as between hyperventilation PaCO2 and the change in CBF (r = 0.97). We conclude that, as measured by PET, CBF decreases significantly during a state of artificial hyperventilation to a degree consistent with results seen using other methods. PET appears to be a valuable tool in the assessment of interventions that could influence CBF.",
author = "Bednarczyk, {E. M.} and Rutherford, {W. F.} and Leisure, {G. P.} and Munger, {M. A.} and Panacek, {Edward A} and Miraldi, {F. D.} and Green, {J. A.}",
year = "1990",
language = "English (US)",
volume = "24",
pages = "456--460",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "5",

}

TY - JOUR

T1 - Hyperventilation-induced reduction in cerebral blood flow

T2 - Assessment by positron emission tomography

AU - Bednarczyk, E. M.

AU - Rutherford, W. F.

AU - Leisure, G. P.

AU - Munger, M. A.

AU - Panacek, Edward A

AU - Miraldi, F. D.

AU - Green, J. A.

PY - 1990

Y1 - 1990

N2 - The use of positron emission tomography (PET) has been well documented as a relatively noninvasive method of measuring cerebral blood flow (CBF), both globally and regionally. The utility of readily detecting alterations in CBF is apparent, particularly when applied to the evaluation of therapeutic interventions thought to influence CBF. We report the effects of hypocapnia, an experimental condition of known cerebral vasoconstriction, in ten normal volunteers. Subjects had brain blood flow evaluated utilizing H2 15O as the positron emitter before and after approximately five minutes of hyperventilation. Baseline CBF was measured as a mean ± SD of 61.2 ± 16.3 mL/min/100 g of tissue. Mean baseline arterial blood gas values were PaO2 107.4 ± 14 mm Hg, PaCO2 37.7 ± 0.89 mm Hg, and pH 7.39 (calculated from mean [H+]). Post hyperventilation, global CBF was measured as 31.1 ± 10.8 mL/min/100 g. Mean arterial blood gas values were PaO2 141.7 ± 21 mm Hg, PaCO2 19.7 ± 5 mm Hg, and pH 7.63 (calculated from mean [H+]). CBF decreased by a mean of 49.5 ± 11 percent. Data analysis using the Student's t-test showed a significant change over baseline in PaCO2 (p < 0.001) and CBF (p < 0.001), in the hyperventilated state. Correlations were noted between the decrease in CBF and change in PaCO2 (r = 0.81) as well as between hyperventilation PaCO2 and the change in CBF (r = 0.97). We conclude that, as measured by PET, CBF decreases significantly during a state of artificial hyperventilation to a degree consistent with results seen using other methods. PET appears to be a valuable tool in the assessment of interventions that could influence CBF.

AB - The use of positron emission tomography (PET) has been well documented as a relatively noninvasive method of measuring cerebral blood flow (CBF), both globally and regionally. The utility of readily detecting alterations in CBF is apparent, particularly when applied to the evaluation of therapeutic interventions thought to influence CBF. We report the effects of hypocapnia, an experimental condition of known cerebral vasoconstriction, in ten normal volunteers. Subjects had brain blood flow evaluated utilizing H2 15O as the positron emitter before and after approximately five minutes of hyperventilation. Baseline CBF was measured as a mean ± SD of 61.2 ± 16.3 mL/min/100 g of tissue. Mean baseline arterial blood gas values were PaO2 107.4 ± 14 mm Hg, PaCO2 37.7 ± 0.89 mm Hg, and pH 7.39 (calculated from mean [H+]). Post hyperventilation, global CBF was measured as 31.1 ± 10.8 mL/min/100 g. Mean arterial blood gas values were PaO2 141.7 ± 21 mm Hg, PaCO2 19.7 ± 5 mm Hg, and pH 7.63 (calculated from mean [H+]). CBF decreased by a mean of 49.5 ± 11 percent. Data analysis using the Student's t-test showed a significant change over baseline in PaCO2 (p < 0.001) and CBF (p < 0.001), in the hyperventilated state. Correlations were noted between the decrease in CBF and change in PaCO2 (r = 0.81) as well as between hyperventilation PaCO2 and the change in CBF (r = 0.97). We conclude that, as measured by PET, CBF decreases significantly during a state of artificial hyperventilation to a degree consistent with results seen using other methods. PET appears to be a valuable tool in the assessment of interventions that could influence CBF.

UR - http://www.scopus.com/inward/record.url?scp=0025343304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025343304&partnerID=8YFLogxK

M3 - Article

C2 - 2343589

AN - SCOPUS:0025343304

VL - 24

SP - 456

EP - 460

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 5

ER -